Healthcare -
Drug Manufacturers - General - NYSE - US
$ 14.585
-2.18 %
$ 3.76 B
Market Cap
4.38
P/E
OGN - COST OF REVENUE
Cost of Revenue OGN - Organon & Co.
2.52 B
LAST VALUE
2.75%
2 YEAR CAGR
-11.73%
5 YEAR CAGR
0.00%
10 YEAR CAGR